New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Creative Medical Technology Holdings, Inc.
CELZ
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

6M

Biotechnology

Next Earning date - 12 Nov 2024

6M

Biotechnology

Next Earning date - 12 Nov 2024

4.25USD
Shape0.08 ( 1.99%)
favorite-chart

Relative Strenght

25
favorite-chart

Volume Buzz

190%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

59%

Quote Panel

Shape
Updated October 13, 2024
1W 45.55 % 1M 25.37 % 3M 16.12 % 1Y -14.66 %

Key Metrics

Shape
  • Market Cap

    5.69M


  • Shares Outstanding

    1.34M


  • Share in Float

    1.30M


  • Dividende

    0


  • Earning Date

    12 Nov 2024


  • Price Target

    4.2529


  • Average Volume

    11468


  • Beta

    5.023


  • Range

    2.65-10.2812


  • Industry

    Biotechnology


  • Website

    https://www.creativemedicaltechnology.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

334.76x

P/S Ratio

0.78x

P/B Ratio

0.0

Debt/Equity

-33716.5%

Net Margin

$-4.1

EPS

How CELZ compares to sector?

P/E Ratio

Relative Strength

Shape

CELZ

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$600K

Shape7400%

2025-Revenue

$2.58

Shape-132%

2025-EPS

$600K

Shape62%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Roth Capital

initialise

Previous: Not converted

2022-02-25

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.07
vs -6.11

Q4.22

arrow
arrow

N/A

-4.37
vs -4.16

Q1.23

arrow
arrow

N/A

-0.70
vs NA

Q2.23

arrow
arrow

N/A

-0.78
vs -0.20

Q3.23

arrow
arrow

N/A

-1.02
vs -0.07

Q4.23

arrow
arrow

N/A

-1.21
vs -4.37

Q1.24

arrow
arrow

N/A

-0.73
vs -0.70

Q2.24

arrow
arrow

N/A

-1.11
vs -0.78

Q3.24

arrow
arrow

N/A

-0.85
vs -1.02

Q4.24

arrow
arrow

N/A

-0.87
vs -1.21

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+450%

55K  vs 10K

Q4.22

arrow
arrow

-73%

18.6K  vs 67.8K

Q1.23

arrow
arrow

-100%

NA  vs 15K

Q2.23

arrow
arrow

-100%

NA  vs 10K

Q3.23

arrow
arrow

-89%

6K  vs 55K

Q4.23

arrow
arrow

-84%

3K  vs 18.6K

Q1.24

arrow
arrow

NA

NA  vs NA

Q2.24

arrow
arrow

NA

8K  vs NA

Q3.24

arrow
arrow

+20%

7.2K  vs 6K

Q4.24

arrow
arrow

+117%

6.5K  vs 3K

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-4%

-0.04
vs -0.09

Q4.22

arrow
arrow

-39%

-0.39
vs -0.04

Q1.23

arrow
arrow

-7%

-0.07
vs -0.39

Q2.23

arrow
arrow

-8%

-0.08
vs -0.07

Q3.23

arrow
arrow

-12%

-0.12
vs -0.08

Q4.23

arrow
arrow

-16%

-0.16
vs -0.12

Q1.24

arrow
arrow

-11%

-0.11
vs -0.16

Q2.24

arrow
arrow

-20%

-0.20
vs -0.11

Institutionnal OwnershipShape

status-upQoQ

Q4.21

arrow
arrow

1

1
vs NA

NA

Earnings Growth

Latest News